As cytokines have been reported to be responsible for some paraneoplastic hematopoietic syndromes in patients with NSCLC, as described above (32), we propose that one potential mechanism to explain these findings could involve systemic IL-6 levels. This evidence concerns the gene IL6 and non-small cell lung carcinoma.